Companies Dominating the Predictive Disease Analytics Landscape
- Anaconda Inc.
- Company Overview
- Business Strategy
- Key Product Offerings
- Financial Performance
- Key Performance Indicators
- Risk Analysis
- Recent Development
- Regional Presence
- SWOT Analysis
- Allscripts Healthcare Solutions Inc.
- Epic System Corporation
- IBM
- McKesson Corporation
- MedeAnalytics, Inc.
- Microsoft Corporation
- Optum
- Philips Healthcare
- Siemens Healthineers
Companies are participating in several growth initiatives such as forming strategic partnerships, and collaborations. Investment in R&D has also been considered a priority, enabling the creation of innovative predictive models tailored to specific diseases and patient populations. Additionally, companies are also focusing on product expansions by incorporating ML and AI capabilities into their analytics solutions. For instance, in September 2023, Google and Apollo Hospitals expanded their partnership aiming to provide an omnichannel healthcare experience in India with online doctor consultations, improved clinician decision-making, telemedicine services, and home delivery of medication.
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
Predictive Disease Analytics Market in 2025 is estimated at USD 3.78 billion.
The global market size was valued at around USD 3.22 billion in 2024 and is projected to grow at a CAGR of more than 21.9%, reaching USD 42.26 billion revenue by 2037.
North America is forecasted to cross USD 14.75 billion by 2037, driven by value-based care models and predictive analytics adoption in healthcare.
The major players in the market include Microsoft Corporation, Optum, Philips Healthcare, Siemens Healthineers, and others.
